155 related articles for article (PubMed ID: 20186105)
21. Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines.
Stephan H; Zakrzewski JL; Bölöni R; Grasemann C; Lohmann DR; Eggert A
Pediatr Blood Cancer; 2008 Feb; 50(2):218-22. PubMed ID: 17973327
[TBL] [Abstract][Full Text] [Related]
22. The relationship between proangiogenic gene expression levels in prostate cancer and their prognostic value for clinical outcomes.
Mori R; Dorff TB; Xiong S; Tarabolous CJ; Ye W; Groshen S; Danenberg KD; Danenberg PV; Pinski JK
Prostate; 2010 Nov; 70(15):1692-700. PubMed ID: 20564320
[TBL] [Abstract][Full Text] [Related]
23. Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas.
Tang XX; Evans AE; Zhao H; Cnaan A; Brodeur GM; Ikegaki N
Med Pediatr Oncol; 2001 Jan; 36(1):80-2. PubMed ID: 11464911
[TBL] [Abstract][Full Text] [Related]
24. [Expression and clinical significance of vascular endothelial growth factor and its receptors in multiple myeloma].
Liu JR; Luo SK; Li J; Su C
Ai Zheng; 2007 Jun; 26(6):652-6. PubMed ID: 17562275
[TBL] [Abstract][Full Text] [Related]
25. L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors.
Wachowiak R; Fiegel HC; Kaifi JT; Quaas A; Krickhahn A; Schurr PG; Erttmann R; Schachner M; Kluth D; Sauter G; Izbicki JR
Ann Surg Oncol; 2007 Dec; 14(12):3575-80. PubMed ID: 17917782
[TBL] [Abstract][Full Text] [Related]
26. [Expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor and sFlt-1 in preeclampsia placenta].
Sun SG; Shen N; Zheng YH; Shang T
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):440-4. PubMed ID: 17083805
[TBL] [Abstract][Full Text] [Related]
27. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells.
Kim CJ; Matsuo T; Lee KH; Thiele CJ
Am J Pathol; 1999 Nov; 155(5):1661-70. PubMed ID: 10550322
[TBL] [Abstract][Full Text] [Related]
29. Neurotrophic receptor, tropomyosin-related kinase B as an independent prognostic marker in gastric cancer patients.
Tanaka K; Mohri Y; Nishioka J; Kobayashi M; Ohi M; Miki C; Tonouchi H; Nobori T; Kusunoki M
J Surg Oncol; 2009 Apr; 99(5):307-10. PubMed ID: 19170129
[TBL] [Abstract][Full Text] [Related]
30. Expression of TrkC in favorable human neuroblastomas.
Yamashiro DJ; Nakagawara A; Ikegaki N; Liu XG; Brodeur GM
Oncogene; 1996 Jan; 12(1):37-41. PubMed ID: 8552397
[TBL] [Abstract][Full Text] [Related]
31. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.
Davidson B; Reich R; Lazarovici P; Nesland JM; Skrede M; Risberg B; Tropé CG; Flørenes VA
Clin Cancer Res; 2003 Jun; 9(6):2248-59. PubMed ID: 12796393
[TBL] [Abstract][Full Text] [Related]
32. Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma.
Li Q; Xu B; Fu L; Hao XS
J Exp Clin Cancer Res; 2006 Sep; 25(3):403-9. PubMed ID: 17167981
[TBL] [Abstract][Full Text] [Related]
33. Biological effects of TrkA and TrkB receptor signaling in neuroblastoma.
Schramm A; Schulte JH; Astrahantseff K; Apostolov O; Limpt Vv; Sieverts H; Kuhfittig-Kulle S; Pfeiffer P; Versteeg R; Eggert A
Cancer Lett; 2005 Oct; 228(1-2):143-53. PubMed ID: 15921851
[TBL] [Abstract][Full Text] [Related]
34. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
[TBL] [Abstract][Full Text] [Related]
35. Expression patterns of Trk-A, Trk-B, GRP78, and p75NRT in olfactory neuroblastoma.
Weinreb I; Goldstein D; Irish J; Perez-Ordonez B
Hum Pathol; 2009 Sep; 40(9):1330-5. PubMed ID: 19386345
[TBL] [Abstract][Full Text] [Related]
36. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
[TBL] [Abstract][Full Text] [Related]
37. Expression of neurotrophin receptor TrkA inhibits angiogenesis in neuroblastoma.
Eggert A; Grotzer MA; Ikegaki N; Liu XG; Evans AE; Brodeur GM
Med Pediatr Oncol; 2000 Dec; 35(6):569-72. PubMed ID: 11107119
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma.
Shen GH; Ghazizadeh M; Kawanami O; Shimizu H; Jin E; Araki T; Sugisaki Y
Br J Cancer; 2000 Jul; 83(2):196-203. PubMed ID: 10901370
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor-II expression is down-regulated in TrkA-transfected SK-N-AS neuroblastoma cells.
Kim CJ; Chi JG; Thiele CJ
Lab Invest; 1999 Aug; 79(8):1007-13. PubMed ID: 10462038
[TBL] [Abstract][Full Text] [Related]
40. Reply to Langer et al. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas.
Crazzolara R; Abrederis K; Kreczy A; Meister B
Med Pediatr Oncol; 2002 Aug; 39(2):146. PubMed ID: 12116069
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]